TB vaccines in clinical development

TB vaccines in clinical development

عرض إصدارات أخرى (2)

The 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 - 24 April 2015, brought together a wide and diverse community involved in tuberculosis vaccine research and development to discuss the current status of, and future directions for this critical effort. This paper summarizes t...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Ginsberg, A, Ruhwald, M, Mearns, H, Mcshane, H
التنسيق:	Journal article
منشور في:	Elsevier 2016

مواد مشابهة

TB vaccines in clinical development
حسب: Ginsberg, AM, وآخرون
منشور في: (2016)

TB vaccines in clinical development
حسب: Ginsburg, A, وآخرون
منشور في: (2016)

TB vaccine development: where are we and why is it so difficult?
حسب: Wilkie, M, وآخرون
منشور في: (2014)

A review of clinical models for the evaluation of human TB vaccines.
حسب: O'Shea, M, وآخرون
منشور في: (2016)

Progress and challenges in TB vaccine development
حسب: Voss, G, وآخرون
منشور في: (2018)

Towards new TB vaccines
حسب: Brazier, B, وآخرون
منشور في: (2020)

Need for more TB vaccine field sites.
حسب: Mcshane, H
منشور في: (2009)

DEVELOPING A NEW TB VACCINE: BOOSTING BCG WITH MVA85A
حسب: Mcshane, H
منشور في: (2008)

Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.
حسب: Minassian, A, وآخرون
منشور في: (2011)

New TB vaccine granted orphan drug status.
حسب: Lang, T, وآخرون
منشور في: (2005)

A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development
حسب: Pepponi, I, وآخرون
منشور في: (2017)

Co-infection with HIV and TB: double trouble.
حسب: Mcshane, H
منشور في: (2005)

Progress and challenges in TB vaccine development [version 1; referees: 2 approved]
حسب: Gerald Voss, وآخرون
منشور في: (2018-02-01)

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data.
حسب: McShane, H, وآخرون
منشور في: (2014)

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data
حسب: McShane, H, وآخرون
منشور في: (2014)

Evaluating aerosol administration of a candidate TB vaccine MVA85A
حسب: Thomas, Z, وآخرون
منشور في: (2014)

Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.
حسب: Angela M Minassian, وآخرون
منشور في: (2011-01-01)

Identification and evaluation of novel protective antigens for the development of a candidate TB subunit vaccine
حسب: Stylianou, E, وآخرون
منشور في: (2018)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults.
حسب: Pathan, A, وآخرون
منشور في: (2012)

Phase I/II clinical trial of MVA85A in individuals with latent tuberculosis: The first subunit TB vaccine in clinical trial
حسب: Sander, C, وآخرون
منشور في: (2005)

A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants
حسب: Odutola, A, وآخرون
منشور في: (2012)

A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants.
حسب: Odutola, A, وآخرون
منشور في: (2012)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
حسب: Pathan, A, وآخرون
منشور في: (2012)

Designing an adaptive phase II/III trial to evaluate efficacy, safety and immune correlates of new TB vaccines in young adults and adolescents
حسب: Rustomjee, R, وآخرون
منشور في: (2013)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
حسب: Tameris, M, وآخرون
منشور في: (2014)

Designing an adaptive phase II/III trial to evaluate efficacy, safety and immune correlates of new TB vaccines in young adults and adolescents.
حسب: Rustomjee, R, وآخرون
منشور في: (2013)

Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.
حسب: Whelan, K, وآخرون
منشور في: (2009)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses
حسب: Tameris, M, وآخرون
منشور في: (2014)

Clinical Development of New TB Vaccines: Recent Advances and Next Steps
حسب: Mark Hatherill, وآخرون
منشور في: (2020-01-01)

Differential cytokine levels in adults induced by a Novel candidate TB boost vaccine, MVA85A-according to previous BCG vaccination status
حسب: Owiafe, P, وآخرون
منشور في: (2012)

Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model
حسب: Pinpathomrat, N, وآخرون
منشور في: (2021)

Tuberculosis vaccines in clinical trials.
حسب: Rowland, R, وآخرون
منشور في: (2011)

Developing an improved vaccine against tuberculosis.
حسب: Mcshane, H
منشور في: (2004)

Bayesian Augmented Clinical Trials in TB Therapeutic Vaccination
حسب: Dimitrios Kiagias, وآخرون
منشور في: (2021-10-01)

Experimental animal modelling for TB vaccine development
حسب: Pere-Joan Cardona, وآخرون
منشور في: (2017-03-01)

Comparison of the safety and immunogenicity of a candidate TB vaccine, MVA85A, given by the intramuscular or intradermal route in BCG-vaccinated adults
حسب: Harris, S, وآخرون
منشور في: (2011)

Insights and challenges in tuberculosis vaccine development
حسب: McShane, H
منشور في: (2019)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.
حسب: Meyer, J, وآخرون
منشور في: (2013)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
حسب: Meyer, J, وآخرون
منشور في: (2013)

Phase I trial evaluating the safety and immunogenicity of candidate TB vaccine MVA85A, delivered by aerosol to healthy M.tb-infected adults
حسب: Riste, M, وآخرون
منشور في: (2021)